Pershing Gold to Present at Rodman and Renshaw Global Investment Conference
Get Alerts PGLC Hot Sheet
Join SI Premium – FREE
LAKEWOOD, Colo., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Pershing Gold Corporation (OTCQB: PGLC) ("Pershing Gold" or the "Company"), an emerging Nevada gold producer on a fast-track to reopen the Relief Canyon Mine, today announced that Debra Struhsacker ("Struhsacker"), Pershing Gold's Senior Vice President, will present at the Rodman and Renshaw 16th Annual Global Investment Conference (the "Conference") in New York City.
The Conference will be held September 8-10, 2014, at the New York Palace Hotel. Struhsacker will be presenting at 10:50am on Tuesday, September 9th.
Struhsacker will provide a Company update during the live presentation and participate in one-on-one meetings with registered conference investors. Attendees include public companies, institutional investors, private investors and business development executives. The Conference is sponsored by H.C. Wainright & Co.
About Pershing Gold Corporation
Pershing Gold is an emerging Nevada gold producer on a fast-track to re-open the Relief Canyon Mine, which includes three open-pit mines and a state-of-the-art, fully permitted and constructed heap leach processing facility. Pershing Gold's landholdings cover over 25,000 acres that include the Relief Canyon Mine asset and lands surrounding the mine in all directions. This land package provides Pershing Gold with the opportunity to expand the Relief Canyon Mine deposit and to explore and make new discoveries on nearby lands.
CONTACT: Jack Perkins
Vice President, Investor Relations
720.974.7254
[email protected]
www.PershingGold.com
Source: Pershing Gold Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoreageRx Launches Four New Supplements for Muscle, Digestion, and GLP-1 Support
- CoreAge Rx Launches Free Digital Wellness Community to Support Patients Through Peer Connection and Education
- CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share